Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-12-10

Clinical Trial Update: Oral Gabapentin and Median Nerve Mobilization in the Treatment of Carpal Tunnel Syndrome [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating the combination of oral gabapentin and median nerve mobilization for carpal tunnel syndrome has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • NEURONTIN (gabapentin)

Snippet

Sponsor: Universidad Europea de Madrid | Conditions: Carpal Tunnel Syndrome | Phase 4 | Status: COMPLETED